[ad_1]
Wall Street’s “fear gauge” has come roaring back this week after a prolonged stretch of quiescence. Its rise is raising questions about how much longer the summer selloff in stocks might continue.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...